Literature DB >> 6861854

Biological variability of multiple dose pharmacokinetics of netilmicin in man.

J Blaser, H Rieder, P Niederer, R Lüthy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6861854     DOI： 10.1007/bf00610062

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  16 in total

1.  A clinical appraisal of the plasma concentration and endogenous clearance of creatinine.

Authors:  P D DOOLAN; E L ALPEN; G B THEIL
Journal:  Am J Med       Date:  1962-01       Impact factor: 4.965

2.  Gentamicin serum concentrations: pharmacokinetic predictions.

Authors:  J H Hull; F A Sarubbi
Journal:  Ann Intern Med       Date:  1976-08       Impact factor: 25.391

3.  The unpredictability of serum concentrations of gentamicin: pharmacokinetics of gentamicin in patients with normal and abnormal renal function.

Authors:  D Kaye; M E Levison; E D Labovitz
Journal:  J Infect Dis       Date:  1974-08       Impact factor: 5.226

4.  Predicted tissue accumulation of netilmicin in patients.

Authors:  D J Edwards; A Mangione; T J Cumbo; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

5.  Influence of the route of administration on the pharmacokinetics of amikacin.

Authors:  J M Lanao; A Dominguez-Gil; J M Tabernero; L Corbacho
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

6.  Basis for an adequate dosage of aminoglycoside antibiotics.

Authors:  R Lüthy
Journal:  Infection       Date:  1980       Impact factor: 3.553

7.  Quantitative nephrotoxicity of gentamicin in nontoxic doses.

Authors:  B Trollfors; K Alestig; I Krantz; R Norrby
Journal:  J Infect Dis       Date:  1980-03       Impact factor: 5.226

8.  Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years.

Authors:  J V Durnin; J Womersley
Journal:  Br J Nutr       Date:  1974-07       Impact factor: 3.718

9.  Comparative effects of tobramycin and gentamicin on glomerular ultrastructure.

Authors:  F C Luft; A P Evan
Journal:  J Infect Dis       Date:  1980-12       Impact factor: 5.226

10.  [Urea and creatinine levels and clearances: observations in 25 healthy subjects for one year (author's transl)].

Authors:  C D Koch; E Arnst; K Rommel
Journal:  J Clin Chem Clin Biochem       Date:  1980-07
View more
  6 in total

1.  Increase of amikacin half-life during therapy in patients with renal insufficiency.

Authors:  J Blaser; S Rüttimann; H Bhend; R Lüthy
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

2.  Interface-area-to-volume ratio of interstitial fluid in humans determined by pharmacokinetic analysis of netilmicin in small and large skin blisters.

Authors:  J Blaser; H L Rieder; R Lüthy
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

3.  Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro model.

Authors:  J Blaser; B B Stone; S H Zinner
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

4.  Impact of netilmicin regimens on the activities of ceftazidime-netilmicin combinations against Pseudomonas aeruginosa in an in vitro pharmacokinetic model.

Authors:  J Blaser; B B Stone; M C Groner; S H Zinner
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

5.  Population pharmacokinetics of netilmicin in short-term prophylactic treatment.

Authors:  Nerea Jauregizar; Jeff A Wald; Ander Astobieta; Jose M Rodriguez Sasiain; John C Lukas; Rosario Calvo
Journal:  Br J Clin Pharmacol       Date:  2003-06       Impact factor: 4.335

Review 6.  Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; S Chaplin; R H Sayce; K L Goa
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.